John B. Ketchum
Director, Tango Therapeutics (United States).
Companies
- Tango Therapeutics (United States)Board member Aug 31, 2023 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tango Therapeutics (United States) TNGX24,937 shares2$559.8K at $22.45Jun 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 5, 2026Granted 4,000 shares of Tango Therapeutics (United States)2
- Jun 5, 2025Granted 6,250 shares of Tango Therapeutics (United States)3
- Jun 5, 2024Granted 4,687 shares of Tango Therapeutics (United States)4
- Aug 29, 2023Granted 10,000 shares of Tango Therapeutics (United States)5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 9, 2025
- 4SEC EDGARForm 4 filed Jun 7, 2024
- 5SEC EDGARForm 4 filed Aug 31, 2023